Manipal Health promoter stake fully encumbered after pledge

Manipal Health Enterprises Limited disclosed that promoter-group entity MEMG International India Private Limited pledged 1,44,92,951 shares, equal to 1.09% of fully diluted share capital, on 24 October 2026. The filing says the new pledge supports Claypond Capital Partners Private Limited’s non-convertible debentures and that encumbrances continue over all 27.70% of promoter-group holdings.

What did Manipal Health disclose about the new pledge?

Manipal Health disclosed the creation of a pledge by MEMG International India Private Limited over 1,44,92,951 equity shares on 24 October 2026. The shares represent 1.09% of Manipal Health’s fully diluted share capital, including outstanding employee stock option plan pool options, according to the Regulation 31 disclosure dated 30 October 2026.

The pledge was created in favour of Vistra ITCL (India) Limited, acting as debenture trustee. MEMG International India Private Limited is a promoter-group entity and held 2,38,20,811 Manipal Health shares, or 1.79% of share capital, in the disclosure. Its stated holding remained 2,38,20,811 shares after the event.

The filing identifies the transaction as a pledge rather than an invocation or release of an existing encumbrance. It says the pledge agreement between MEMG International India Private Limited and Vistra ITCL (India) Limited was dated 24 October 2026 and may be amended from time to time.

How much of Manipal Health’s promoter holding is encumbered?

Manipal Health said encumbrances continue over 100% of the promoter and promoter-group holding, which totals 36,90,38,332 shares or 27.70% of fully diluted share capital. The new pledge itself equals 3.93% of that aggregate promoter holding, because it covers 1.09% of the company’s share capital.

The filing distinguishes the fresh pledge from the group-wide encumbrance total. It states that certain covenants in the nature of encumbrance had already applied to the same MEMG International India Private Limited shares under disclosures dated 14 August 2026 and 3 September 2026. Therefore, the 24 October pledge covers shares already subject to those covenants and does not add shares to that entity’s holding.

The 100% encumbrance statement includes pledges, non-disposal undertakings and covenants in the nature of encumbrance. It does not mean that every underlying Manipal Health share is necessarily subject to the same legal mechanism or held by the same promoter entity.

Which promoter holdings are covered by Manipal Health encumbrances?

Manipal Health reported that the 27.70% promoter and promoter-group stake is covered through multiple arrangements involving several entities. Manipal Global Health Services held 23,21,47,755 shares, or 17.43%, and the filing recorded that entire holding as already encumbered, including through an indirect encumbrance arising from a pledge over 100% of Manipal Global Health Services.

Cypress Holdings held 4,91,72,520 shares, or 3.69%, while Manipal Education and Medical Group India Private Limited held 5,65,92,913 shares, or 4.25%. The filing also listed Dr. Ranjan Ramdas Pai with 21,80,790 shares, or 0.16%, and Manipal Research & Management Services International with 51,23,543 shares, or 0.38%.

The earlier arrangements included a non-disposal undertaking over 6,74,61,476 Manipal Health shares held by Manipal Global Health Services, equal to 5.06% of share capital, and one over Cypress Holdings’ 4,91,72,520 shares. The disclosure also describes a covenant in the nature of encumbrance over the full 36,90,38,332-share promoter and promoter-group stake, created on 25 August 2026.

Compared with that 25 August covenant over 27.70% of share capital, the 24 October event is narrower at 1.09%. However, because the new pledge applies to shares already within the prior covenant framework, the filing reports no change to the group’s 100% encumbered promoter holding.

Why were Manipal Health shares pledged for Claypond debentures?

Manipal Health said the pledge relates to non-convertible debentures, or NCDs, issued by Claypond Capital Partners Private Limited under a debenture trust deed dated 25 August 2026. The NCD issuance can aggregate up to Rs 500 crore, and Vistra ITCL (India) Limited acts as the debenture trustee for the arrangement.

The Claypond NCDs are described as unlisted, unrated, secured, non-convertible and redeemable debentures. The filing identifies nine debenture holders, including 360 ONE PRIME LIMITED, 360 ONE PORTFOLIO MANAGERS LIMITED, 360 ONE WAM LIMITED, 360 ONE INCOME OPPORTUNITIES FUND - SERIES 7, SAK INDUSTRIES PRIVATE LIMITED and Sonnet Trade and Investments Pvt Ltd.

The stated end uses for amounts raised through the Claypond NCDs include on-lending to group entities for repayment of existing debt, repayment of existing debt, general corporate purposes, investments, inter-corporate deposits and transaction-related expenses. The filing presents these as purposes for the debt proceeds and does not state that Manipal Health itself is a borrower or recipient.

Manipal Health is specifically recorded as not being a party to the pledge agreement or the Claypond debenture trust deed. The parties to the 24 October pledge agreement are MEMG International India Private Limited as pledgor and Vistra ITCL (India) Limited as debenture trustee.

What security details did Manipal Health report for the pledge?

Manipal Health reported a value of Rs 904 crore for the shares covered by the 24 October pledge and an amount involved of Rs 500 crore. The disclosure gave a security-cover ratio of 1.81 for this event, calculated as the reported share value divided by the stated amount involved.

For comparison, the filing listed the 25 August covenant in the nature of encumbrance over 36,90,38,332 shares at a stated share value of Rs 28,262.80 crore against Rs 500 crore, with a reported ratio of 56.53. It also listed prior consolidated encumbrance information with a share value of Rs 24,910 crore, an amount involved of Rs 15,905 crore and a ratio of 1.57.

The filing notes that the values relate to shares subject to the relevant disclosed encumbrance rather than all shares held. It further says the 1.57 figure is a consolidated calculation and does not represent asset cover separately for each financing.

Conclusion

Manipal Health’s 30 October disclosure records a new pledge over 1.09% of share capital for Claypond Capital Partners Private Limited’s Rs 500 crore NCDs, while confirming that the entire 27.70% promoter and promoter-group stake remains encumbered. The key change is the legal form of encumbrance over 1,44,92,951 MEMG International India Private Limited shares, not an expansion of the promoter group’s disclosed shareholding.

The next disclosure to watch is any amendment, release or invocation involving the 24 October pledge agreement or the Claypond NCDs, which the filing says may be amended from time to time. Future filings may also show whether the stated 100% encumbrance level, the Rs 500 crore NCD amount or the status of the existing non-disposal undertakings and covenants changes.